Avextra Unveils Promising Study Results at Major Pain Congress
New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic Pain
News Release
Bensheim, Germany 13 March 2025 At its annual congress in Fran…